News
Chicago TribuneSkepticism grows around Medco/Express Scripts dealReutersBy Diane Bartz | WASHINGTON (Reuters) - Objections to Express Scripts' $29 billion plan to buy rival pharmacy benefits manager Medco Health Solutions are accumulating as US antitrust regulators weigh whether they have enough evidence to stop the
US HOT STOCKS: NCR, Coinstar, Anadarko Active In Late TradingWall Street JournalShares of pharmacy-benefit managers Express Scripts Inc
News
Considering the information of three randomized, multicenter, double, blind clinical studies and a retrospective analysis of the medical documentation, FDA approved on October 7, 2011 Tadalafil medication for the treatment of erectile dysfunction accompanied with primary and secondary symptoms of benign prostatic hyperplasia (BPH) in men above 45 years
In spite of low rates and stagnation of industrial development, the pharmaceutical market shows a dynamical growth